Trial
NCT03639415
Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
Phase IVWITHDRAWNSAFETYConfidence: HIGH
Sponsor
Fujian Cancer Hospital
Collaborators
—
Condition
Cancer Pains
Intervention
Increasing the Controlled-Release Oxycodone dose frequency
Why stopped
There is no fund to support
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-03-08